Ellis Neufeld is Appointed as New Associate Editor of Blood
Blood Journals Portfolio shared a post on LinkedIn:
”We’re pleased to welcome another new Associate Editor to Blood!
Dr. Ellis Neufeld trained as a pediatric ‘classical’ hematologist and geneticist and is an experienced clinical investigator in blood disorders.
He has led observational and interventional studies in thalassemia, iron chelation, ITP, and hemophilia.
He is a founding leader of the ICON ITP consortium.
For NHLBI he has served on steering committees for multicenter clinical trial groups in Thalassemia (TCRN) and Transfusion Medicine/Hemostasis (TMHCRN); and he presently serves on the NHLBI Board of External Experts.
In ‘bedside to bench’ translational studies, he elucidated the role of the SLC19A2 transporter gene in Thiamine-Responsive Anemia, discovered a rare GATA-1 mutation in X-linked thalassemia, and studied the dominant sickling mutation, Hemoglobin Jamaica Plain.
After 32 years at Boston Children’s Hospital, he moved to St. Jude Children’s Research Hospital in 2017 to serve as Chief Medical Officer.
He is still currently there as Executive Vice President, Clinical Director, Physician-in-Chief, and John and Lorine Thrasher Endowed Chair in Pediatric Medicine.
His early research training included a PhD on platelet arachidonate metabolism, and a postdoc studying gp91-phox expression in myeloid cells.
The Blood Editorial Team is lucky to have Dr. Neufeld on board.
He started this position January 1 and we couldn’t be more ecstatic.”

Stay updated with Hemostasis Today.
-
Feb 25, 2026, 12:02WFH Continues to Advance More Precise and Sustainable Care for People with Bleeding Disorders
-
Feb 25, 2026, 09:14Nominations are Open for 2027 Committee and Leadership Positions – ASH
-
Feb 25, 2026, 09:08Bastu Odoka: Closing the Gap on Anti-D Prophylaxis in Maternal Care
-
Feb 25, 2026, 08:53Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
-
Feb 25, 2026, 08:40Matthew Flick։ A Great Gordon Research Conference on Plasminogen Activation and Extracellular Proteolysis
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium
-
Feb 24, 2026, 16:01Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
-
Feb 24, 2026, 15:58Anastasia Conti: Honored to Receive the Roche Foundation Grant for Independent Research in Onco-Hematology